Quick facts about Optune
What Optune is
How Optune works4
How Optune is used5
What Optune is
Optune is a noninvasive, portable device that is classified as durable medical equipment (DME).
How Optune works4
Optune delivers Tumor Treating Fields (TTFields) to selectively disrupt mitosis in dividing cancer cells.4 To learn more, visit Optune MOA.
How Optune is used5
Transducer arrays are applied to the shaved scalp and must be changed at least 2 times per week (every 4 days at most)
Portable for use in normal daily activities
Note: Avoid activities that may result in the device or transducer arrays becoming wet. Getting the device wet may cause it damage
Optune should be switched on ≥18 hours per day
Compliance was a predictor of improved overall survival in both the newly diagnosed GBM and recurrent GBM pivotal studies
Connect patients appropriate for Optune with an experienced Optune user through the Buddy Program.
Experienced users, known as Optune Ambassadors, can speak to their experiences around incorporating Optune into daily life. Have your patients call 1-844-247-1636 or register online.
Brian is an Optune patient.
Patient image reflects the health status of the patient at the time the photo was taken.
Starting patients on Optune
1. Prescribe: Certified physician prescribes Optune. Optune is available at more than 700 centers across the United States.3 To find out if there is a center near you, visit the Certified Treatment Centers page.
2. Submit: Prescription Order Form and supporting documents.
3. Support: Once the prescription is processed, Novocure supports your patients through the reimbursement process and will assign your patient a designated Device Support Specialist (DSS).
4. Initiate: For your convenience, there are 2 ways to get patients started on Optune:
Home 
In your office
DSS will deliver the Optune Treatment Kit and will complete live personalized technical training.
Optune can only be prescribed by certified physicians. Certification training can be provided to you by Novocure, or you can refer your patient to a certified physician.
References: 1. Stupp R, Taillibert S, Kanner A, et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 2017;318(23):2306-2316. 2. Novocure. Novocure (NVCR) q4 2017 results. https://3sj0u94bgxp33grbz1fkt62h-wpengine.netdna-ssl.com/wp-content/uploads/2018/02/NVCR_2017Q4_Earnings_Presentation_vF.pdf. Published February 22, 2018. Accessed March 20, 2018. 3. Novocure Data on File OPT-115.1. 4. Optune Instructions For Use. Novocure 2016. 5. Optune Patient Information and Operation Manual. Novocure 2017.